Shire has formed a multi-year supply agreement with Albany Molecular Research Inc. (AMRI) for an undisclosed product. The terms of the agreement were kept confidential. This is the second such multi-year agreement between Shire and AMRI as AMRI has also been supplying a neuroscience product to Shire.

“This agreement builds on the long-standing development and manufacturing relationship between Shire and AMRI,” said William S. Marth, President and CEO of AMRI, in a company statement. “This long-term contract with Shire illustrates our global and growing integrated API [active pharmaceutical ingredient] contract manufacturing business well, and we look forward to continuing our relationship.”

Source: AMRI